Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, [...]

Polaryx Therapeutics, Inc has selected a leading contract research organization [...]

GSK announced that the European Commission has approved Exdensur (depemokimab) [...]

ViiV Healthcare will present new data from its long-acting and [...]

Compass Pathways has reported that its second pivotal Phase 3 [...]

FundaMental Pharma GmbH will present new preclinical data on its [...]

Oncoinvent will present final 24-month follow-up data from its Phase [...]

Neupulse, a UK-based neurotherapeutics company, has raised £3 million in [...]

Kidswell Bio and Treehill Partners have launched a US-based regenerative [...]

Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]